Top Gainers & Losers: Nifty Slips 304 Points as Pharma Gains Amid Broad Market Sell-off Trend | 28 Sept 2026, 12:00 PM IST
By ThePip Desk
The Nifty 50 fell 1.31% to 22,836.95 on Monday. While pharma stocks saw minor gains, broad selling pressure dragged down the banking and consumer sectors.
The Indian equity markets faced significant selling pressure on Monday, September 28, 2026, as the Nifty 50 index declined by 304 points to close at 22,836.95. The Nifty Bank index also saw a sharp correction, finishing the session down 1.75%.
Top Gainers
| Company | Price | Change% |
|---|---|---|
| Dr. Reddy’s Laboratories Ltd. | 1219.2 | +1.52 |
| HDFC Life Insurance Company Ltd. | 533.75 | +0.52 |
The pharmaceutical sector provided a rare bright spot, led by Dr. Reddy’s Laboratories. The stock rose following the company’s launch of NIVORZ in India, a move designed to strengthen its oncology portfolio and expand its immuno-oncology footprint. HDFC Life Insurance also managed to post gains in a difficult session.
Top Losers
| Company | Price | Change% |
|---|---|---|
| Adani Enterprises Ltd. | 2836.5 | −2.74 |
| Tata Consumer Products Ltd. | 959.4 | −2.42 |
| Tata Motors Passenger Vehicles Ltd. | 283.75 | −2.31 |
| Bharat Electronics Ltd. | 384.65 | −2.26 |
| Adani Ports and SEZ Ltd. | 1749.1 | −2.18 |
Selling pressure was widespread across the market, impacting diverse sectors including infrastructure, consumer goods, and automotive. Adani Enterprises led the decliners despite recent news regarding its arm raising primary equity capital for airport holdings. Other major laggards included Tata Consumer Products, Tata Motors, and HDFC Bank, reflecting a cautious sentiment among investors as the banking and industrial sectors faced heavy liquidation.
The lopsided performance between the singular pharma gains and the broad-based decline across banking and industrials signals a defensive shift in market sentiment.